Keith Manchester - Insider Trading & Ownership

Location
C/O Roivant Sciences Ltd., 11 12 St. James's Square Suite 1, 3 Rd Fl, London, United Kingdom
Summary
The estimated net worth of Keith Manchester is at least $366M dollars as of November 21, 2025. Keith Manchester is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $365M. Keith Manchester is the Director of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $358K.
Signature
/s/ Keith Manchester
All Insider Reports
All Insider Reports

Ownership of Keith Manchester

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. Director $365M -$26.3M -6.72% Nov 19, 2025
ABUS Arbutus Biopharma Corp Director $358K Aug 14, 2024

Insider Transactions Reported by Keith Manchester:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.